Leveraging massive databases of peer-reviewed scientific research available, our EDS team takes an innovative approach to epigenetics and systems biology with the goal of normalizing gene expression. Our team thinks outside of the box as we study and test thousands of supplements combinations against dysregulated genes associated with breast cancer. In contrast to most traditional treatments that target one gene, our team has identified and target more than 100 genes in the development of our supplement protocols. Our Indigo supplement protocol is non-toxic and can be used as a stand-alone option or as complementary to traditional treatments.
Simply said … Everything that we do is backed by science. This fact helps medical providers feel confident in choosing our products to aid in their patients fight against breast cancer, and it relieves the stress of patients who sometimes are unsure of whether a product will have any benefit to them.